From the San Francisco (USA December 2008.

GR-Ytech Pharma presents a new advance in the treatment of sickle cell diseaseERYtech Pharma has been chosen to the first pre-clinical results with its product GR – ARA1 on sickle cell anemia during the 50th Annual Meeting of the American Society of present receive Hematology , from the San Francisco (USA December 2008. December 2008.

The most advanced product, was recently the subject of a Phase II trial for acute lymphoblastic leukemia, while other conditions are explored, especially in solid tumors. Several other products are also in development.Read the full story atglobal pharmaceutical market pharmaceutical Research & Development Overview Advanced Options in the treatment of diseasesmay be more new research reports by the publisher can be found at Kalorama Information page.The research report provides an up-close look at the R & D pipeline of the top 50 pharmaceutical companies worldwide in terms of sales. Merck & Co. Most important market issues and trend, extract revenues for all the pharmaceutical and biopharmaceutical products and providing estimates and forecasts through 2016 in global biopharmaceutical market.

Related Posts

Other Posts From Category "cosmetic surgery":